Related Experiment Video
Updated: May 7, 2026
06:26
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
The genetics of NAFLD.
Quentin M Anstee1, Christopher P Day
1Liver Research Group, Institute of Cellular Medicine, The Medical School, Newcastle University, 4th Floor, William Leech Building, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.
Nature Reviews. Gastroenterology & Hepatology
|September 25, 2013
Summary
Non-alcoholic fatty liver disease (NAFLD) is complex, influenced by genetics and environment. Research explores genetic factors like PNPLA3 to understand disease progression and identify therapeutic targets.
Area of Science:
- Hepatology
- Genetics
- Epigenetics
Background:
- Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum from simple steatosis to cirrhosis.
- Significant interpatient variability exists in NAFLD severity and progression.
- NAFLD is a complex trait influenced by polygenic background and environmental factors.
Purpose of the Study:
- To review the current understanding of genetic and epigenetic factors in NAFLD pathogenesis.
- To discuss specific genetic modifiers influencing NAFLD progression.
- To highlight the role of genes identified through genome-wide association studies, such as PNPLA3.
Main Methods:
- Review of current scientific literature on NAFLD genetics and epigenetics.
- Discussion of findings from genome-wide association studies (GWAS).
- Analysis of mechanisms by which specific genes impact NAFLD progression.
Main Results:
- Genetic factors play a crucial role in NAFLD pathogenesis and progression.
- Genes like PNPLA3, identified via GWAS, significantly influence disease severity.
- Epigenetic modifications are also implicated as modifiers of NAFLD.
Conclusions:
- Understanding the genetic architecture of NAFLD is key to deciphering disease variability.
- Targeting specific genetic pathways, like those involving PNPLA3, may offer therapeutic strategies.
- Further research into genetic and epigenetic modifiers is essential for personalized NAFLD management.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...